KCT0008709
Not yet recruiting
未知
A multi-center, single-arm clinical study for the efficacy and safety of '10THERMA' on tissue coagulation and skin rejuvenation
Korean Society for Laser Medicine and Sugery0 sites31 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Factors influencing health status and contact with health services
- Sponsor
- Korean Society for Laser Medicine and Sugery
- Enrollment
- 31
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Adults between the ages of 30 and 70
- •2\) Those who meet all of the following wrinkle scales
- •\- Those who want temporary improvement of both crow's feet and those who have a resting (expressionless) Crow's Feet Grading Scale of 1\-2 points
- •\- Those who want temporary improvement of cheek wrinkle and have a cheek line grading scale of 1\-2 points
- •3\) Those who agree to stop all dermatological treatments or treatments, including wrinkle improvement of the facial area, during this clinical trial
- •4\) Those who agree to take a picture of the facial area, including the eye area
- •5\) Those who voluntarily decide to participate in this clinical trial and agree to the subject consent form in writing
Exclusion Criteria
- •1\) Those who have undergone cosmetic treatment such as laser, phototherapy, or surgery on the face within the last 6 months, or have undergone filler treatment using collagen, hyaluronic acid filler, or other materials
- •2\) Those who have received radiotherapy in the facial area or have a history of chemotherapy and a history of malignant tumors
- •3\) Those who have a history of infection, dermatitis, rash and heat\-stimulated diseases such as herpes simplex and herpes zoster (including severe acne, fever or light, various allergies to beauty products, etc.), and those who have used steroid drugs
- •4\) Those who have a history of keloid scarring, hypertrophic scarring, and abnormal wound healing
- •5\) Those who have used whitening agents (Hydroquinone, Tranexamic acid, etc.), Isotretinoid (or Retinoid), light\-sensitive drugs, and steroid drugs within the last 6 months
- •6\) Women who are pregnant and breastfeeding (those who plan to become pregnant during the clinical trial or do not agree to appropriate contraceptive methods)
- •7\) Other investigators judged to be inappropriate for this clinical trial
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
PASSAGE Clinical TrialJPRN-jRCT2032220496Kawahara Kazuo51
Active, not recruiting
Phase 3
Study on the endovascular visualization capability of an OFDI catheterJPRN-jRCT2052190025Hirata Ken-ichi20
Active, not recruiting
Phase 1
A clinical study, conducted in several sites in Belgium, investigating the administration at patient's home of the new subcutaneous formulation of the drug trastuzumab for treating patients suffering from a type of breast cancer at early stage, called HER2-positive early breast cancer.TO INVESTIGATE THE AT HOME ADMINISTRTATION OF TRASTUZUMAB SUBCUTANEOUS VIAL FOR THE TREATMENT OF PATIENTS WITH HER2-POSITIVE EARLY BREAST CANCER.Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2013-000123-13-BEV ROCHE SA100
Recruiting
Phase 3
A study to investigate the pharmacokinetics and safety of dupilumab in participants >=2 years to < 12 years of age with uncontrolled chronic spontaneous urticaria (CSU) or chronic inducible cold urticaria (CICU)JPRN-jRCT2031220733Tanaka Tomoyuki24
Completed
Not Applicable
Prospective Multi-Center, Single Arm Study of the Shockwave Coronary Rx Lithoplasty® System in Coronary Arteriesarterial stenosisstenotic coronary arteries10011082NL-OMON43455Shockwave Medical Inc.15